Literature DB >> 19286508

Naturally occurring sheep-associated malignant catarrhal fever in North American pigs.

Ana Alcaraz1, Amy Warren, Carney Jackson, Jennifer Gold, Morgan McCoy, Soon Hon Cheong, Sam Kimball, Steve Sells, Naomi S Taus, Tom Divers, Hong Li.   

Abstract

Two cases of sheep-associated malignant catarrhal fever (MCF) in pigs were diagnosed on a small farm in New York, and in Kentucky. In both cases, the initial diagnosis was based on histopathological changes representing typical lymphoproliferative vasculitis in multiple tissues of the affected pigs. Ovine herpesvirus 2 (OvHV-2) DNA was detected by polymerase chain reaction in the tissues of affected pigs in both cases. The amplified sequences were identical between the clinically affected pigs and the OvHV-2-infected sheep. Additional virological and bacteriological examination showed that the affected pigs were negative for agents that cause Aujeszky's disease, classical swine fever, porcine enterovirus, and rabies. An antibody against a conserved epitope among MCF viruses was detected in 1 clinically affected pig and 2 unaffected cohort pigs, as well as in all the associated sheep. To the authors' knowledge, this is the first report of porcine MCF in North America, and suggests that OvHV-2 is associated with clinical MCF in pigs.

Entities:  

Mesh:

Year:  2009        PMID: 19286508     DOI: 10.1177/104063870902100214

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  2 in total

Review 1.  A review of the epidemiological, clinical, and pathological aspects of malignant catarrhal fever in Brazil.

Authors:  Selwyn Arlington Headley; Thalita Evani Silva de Oliveira; Cristina Wetzel Cunha
Journal:  Braz J Microbiol       Date:  2020-06-15       Impact factor: 2.476

2.  Malignant Catarrhal Fever in Cattle in the Irkutsk Region.

Authors:  Olga Zakharova; Nadezhda Toropova; Olga Burova; Ilya Titov; Ivan Meltsov; Andrey Blokhin
Journal:  J Vet Res       Date:  2020-05-12       Impact factor: 1.744

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.